Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Targeting Transferrin Receptor 2: A Novel "Erythropoiesis-Stimulating Approach" in a Model of Anemia of Chronic Kidney Disease

Violante Olivari, MSc, Maria Rosa Lidonnici, PhD, Mariateresa Pettinato, Laura Silvestri, PhD, Giuliana Ferrari, PhD, Clara Camaschella, MD, Antonella Nai, PhD

Blood (2019) 134 (Supplement_1): 956.

https://doi.org/10.1182/blood-2019-125783

Published: 2019

Journal Articles

Monoclonal Gammopathy of Undetermined Significance (MGUS): Indications for Pre-Diagnostic Testing, Subsequent Diagnoses, and Follow-up Practice

Aishwarya Ravindran, MBBS, Kandace A. Lackore, BS, Amy E. Glasgow, MHA, Matthew T. Drake, MD PhD, Ronald S. Go, MD

Blood (2018) 132 (Supplement 1): 2224.

https://doi.org/10.1182/blood-2018-99-118213

Published: 2018

Journal Articles

A Single Institution Retrospective Analysis of the Effect of Erythropoiesis Stimulating Agents in Patients with Multiple Myleoma

Benjamin M Parsons, DO, Andrew J Borgert, PhD, Angela Smith, MA, Daniel Arndorfer

Blood (2016) 128 (22): 5701.

https://doi.org/10.1182/blood.V128.22.5701.5701

Published: 2016

Journal Articles

Poor ESA Responders As Defined By Week 4 Hemoglobin Response Have Greater ESA Dosing but Worse Cardiovascular Outcomes in Patients with Anemia of Chronic Kidney Disease (CKD) Not on Dialysis

Robert C. Kane, MD, Qing Xu, PhD, Rajeshwari Sridhara, PhD, Justin Earp, PhD

Blood (2014) 124 (21): 4016.

https://doi.org/10.1182/blood.V124.21.4016.4016

Published: 2014

Journal Articles

The Erythropoiesis Stimulating Agent Omontys/Peginesatide up-Modulates Erythroid Progenitor Formation, and Cell Surface Erythropoietin Receptor Levels.

Rakesh Verma, Ph.D, Jennifer M Green, PhD, Karen Leu, Richard B Mortensen, Peter R. Young, Peter J Schatz, Don M. Wojchowski, PhD

Blood (2012) 120 (21): 2089.

https://doi.org/10.1182/blood.V120.21.2089.2089

Published: 2012

Journal Articles

Prevalence of 25-Hydroxyvitamin D Deficiency in Korean Patients with Anemia

Eun-Hyung Yoo, MD, Hyun-Jung Cho, MD, PhD

Blood (2012) 120 (21): 5164.

https://doi.org/10.1182/blood.V120.21.5164.5164

Published: 2012

Journal Articles

Targeting the Hepcidin Pathway with RNAi Therapeutics for the Treatment of Anemia

Akin Akinc, PhD, Amy Chan-Daniels, PhD, Alfica Sehgal, PhD, Don Foster, Brian R Bettencourt, PhD, Julia Hettinger, Tim Racie, Justin Aubin, Satya Kuchimanchi, PhD, Hila Epstein-Barash, PhD, Tomoko Nakayama, PhD

Blood (2011) 118 (21): 688.

https://doi.org/10.1182/blood.V118.21.688.688

Published: 2011

Journal Articles

Anemia of Chronic Kidney Disease – Hepcidin Is a Predictor,

Srila Gopal, MD, Rao Madhumathi, MD, PhD, FRCP(E), Damien R Ashby

Blood (2011) 118 (21): 3182.

https://doi.org/10.1182/blood.V118.21.3182.3182

Published: 2011

Journal Articles

Liver Specific Delivery of siRNA Targeting EGLN Prolyl Hydroxylases Activates Hepatic Erythropoietin Production and Stimulates Erythropoiesis,

William Querbes, PhD, Roman Bogorad, PhD, Javid Moslehi, MD, Akin Akinc, PhD, Jamie Wong, PhD, Chris Zurenko, June Qin, Julia Hettinger, Satya Kuchimanchi, PhD, Klaus Charisse, PhD, Dinah WY Sah, PhD, Kevin Fitzgerald, PhD, Victor Kotelianski, MD, PhD, William G. Kaelin, Jr., MD

Blood (2011) 118 (21): 3161.

https://doi.org/10.1182/blood.V118.21.3161.3161

Published: 2011

Journal Articles

Heme, Iron, and the Kidney

Karl A. Nath, MBChB

Blood (2010) 116 (21): SCI-26.

https://doi.org/10.1182/blood.V116.21.SCI-26.SCI-26

Published: 2010

Journal Articles

Comparison between Intravenous Iron and Oral Iron Preparations for the Treatment of Anemia of Chronic Kidney Disease - A Systematic Review and Meta-Analysis

Anat Gafter-Gvili, MD, Benaya Rozen-Zvi, MD, Mical Paul, MD, Leonard Leibovici, MD, Gafter Uzi, MD, Ofer Shpilberg

Blood (2007) 110 (11): 3748.

https://doi.org/10.1182/blood.V110.11.3748.3748

Published: 2007

Journal Articles

Anemia of Chronic Renal Failure Is Associated with Much Higher Frequency of Apoptosis in Erythroid Progenitor in a Mouse Model.

Tatsuo Oyake, MD, PhD, Shigeki Ito, MD, PhD, Shugo Kowata, MD, Kazunori Murai, MD, Takashi Sawai, MD, PhD, Yoji Ishida, MD, PhD

Blood (2006) 108 (11): 1293.

https://doi.org/10.1182/blood.V108.11.1293.1293

Published: 2006

Journal Articles

The Role of Erythropoietin in Vascular Endothelial Cells and Thrombosis.

Kenneth R. LaMontagne, PhD, Khalil Bdeir, PhD, Maria E. Carinato, MS, Jeannene Butler, BS, Douglas B. Cines, MD, Francis X. Farrell, PhD

Blood (2005) 106 (11): 4035.

https://doi.org/10.1182/blood.V106.11.4035.4035

Published: 2005

Journal Articles

Anaemia Management in Patients on Peritoneal Dialysis in Portugal: A Nationwide Multicenter Survey.

Patrícia Q. Branco, MD, Cristina P. Abreu, MD, Pedro Pessegueiro, MD, Manuel Amoedo, MD, Anabela Rodrigues, MD, Antonio Cabrita, MD, Margarida Bruges, MD, Edgar de Almeida, MD, Mateus Martins Prata, MD, PhD

Blood (2005) 106 (11): 3753.

https://doi.org/10.1182/blood.V106.11.3753.3753

Published: 2005

Journal Articles

Multiple Cause of Loss of Recombinant Erythropoietin Efficacy: Physicians Beware.

Kenneth R. Carson, MD, Dennis W. Raisch, PhD, Charles L. Bennett, MD

Blood (2005) 106 (11): 2261.

https://doi.org/10.1182/blood.V106.11.2261.2261

Published: 2005

NARROW

Targeting Transferrin Receptor 2: A Novel "Erythropoiesis-Stimulating Approach" in a Model of Anemia of Chronic Kidney Disease

Monoclonal Gammopathy of Undetermined Significance (MGUS): Indications for Pre-Diagnostic Testing, Subsequent Diagnoses, and Follow-up Practice

A Single Institution Retrospective Analysis of the Effect of Erythropoiesis Stimulating Agents in Patients with Multiple Myleoma

Poor ESA Responders As Defined By Week 4 Hemoglobin Response Have Greater ESA Dosing but Worse Cardiovascular Outcomes in Patients with Anemia of Chronic Kidney Disease (CKD) Not on Dialysis

The Erythropoiesis Stimulating Agent Omontys/Peginesatide up-Modulates Erythroid Progenitor Formation, and Cell Surface Erythropoietin Receptor Levels.

Prevalence of 25-Hydroxyvitamin D Deficiency in Korean Patients with Anemia

Targeting the Hepcidin Pathway with RNAi Therapeutics for the Treatment of Anemia

Anemia of Chronic Kidney Disease – Hepcidin Is a Predictor,

Liver Specific Delivery of siRNA Targeting EGLN Prolyl Hydroxylases Activates Hepatic Erythropoietin Production and Stimulates Erythropoiesis,

Heme, Iron, and the Kidney

Comparison between Intravenous Iron and Oral Iron Preparations for the Treatment of Anemia of Chronic Kidney Disease - A Systematic Review and Meta-Analysis

Anemia of Chronic Renal Failure Is Associated with Much Higher Frequency of Apoptosis in Erythroid Progenitor in a Mouse Model.

The Role of Erythropoietin in Vascular Endothelial Cells and Thrombosis.

Anaemia Management in Patients on Peritoneal Dialysis in Portugal: A Nationwide Multicenter Survey.

Multiple Cause of Loss of Recombinant Erythropoietin Efficacy: Physicians Beware.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only